CASI Pharmaceuticals, Inc. (CASI): Price and Financial Metrics
CASI Pharmaceuticals, Inc. (CASI)
Today's Latest Price: $3.46 USD
Updated Jan 19 4:00pm
Add CASI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CASI Stock Summary
- For CASI, its debt to operating expenses ratio is greater than that reported by only 0.52% of US equities we're observing.
- CASI's price/sales ratio is 36.03; that's higher than the P/S ratio of 93.13% of US stocks.
- As for revenue growth, note that CASI's revenue has grown 318.48% over the past 12 months; that beats the revenue growth of 97.84% of US companies in our set.
- Stocks that are quantitatively similar to CASI, based on their financial statements, market capitalization, and price volatility, are ADMP, MTBC, JAGX, TEUM, and XXII.
- Visit CASI's SEC page to see the company's official filings. To visit the company's web site, go to www.casipharmaceuticals.com.
CASI Stock Price Chart Interactive Chart >
CASI Price/Volume Stats
| Current price | $3.46 | 52-week high | $3.60 |
| Prev. close | $3.39 | 52-week low | $1.15 |
| Day low | $3.39 | Volume | 642,500 |
| Day high | $3.60 | Avg. volume | 552,627 |
| 50-day MA | $2.56 | Dividend yield | N/A |
| 200-day MA | $2.13 | Market Cap | 428.85M |
CASI Pharmaceuticals, Inc. (CASI) Company Bio
CASI Pharmaceuticals, Inc., a late-stage biopharmaceutical company, acquires, develops, and commercializes therapeutics addressing cancer and other unmet medical needs in China. The company was founded in 1991 and is based in Rockville, Maryland.
Loading social stream, please wait...